Douglas Roblin to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications Douglas Roblin has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
Connection Strength
0.142
-
Statin use and risk of multiple myeloma: An analysis from the cancer research network. Int J Cancer. 2017 08 01; 141(3):480-487.
Score: 0.126
-
Outpatient use of cardiovascular drugs during pregnancy. Pharmacoepidemiol Drug Saf. 2008 Mar; 17(3):240-7.
Score: 0.017